Thursday, January 11, 2018

How Biotech is Trying to fix Hearing Loss

"At least half a dozen biotechs are working on potential breakthroughs in the way hearing loss is treated. But it’s unclear if the drugs they’re developing will be ready in time to help hearing-impaired boomers, some of whom are in their 70s," the Boston Glove Reports. David Lucchino, chief executive of Frequency, told the paper:
“There’s a fundamental transformation happening in hearing regeneration. We’re figuring out how to hot-wire the hair cells in the inner ear that die off during a lifetime of being exposed to noise.”
Read the full article here.

No comments: